Nazarii Sabat

Nazarii Sabat

Auto-generated profile, based on publicly available information

Nazarii Sabat

Institut Pasteur Université Paris Cité CNRS UMR3523 Department of Structural Biology and Chemistry Laboratory for Bioorganic Chemistry of Nucleic Acids 28, rue du Docteur Roux 75724 Paris Cedex 15 France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2020 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
PMPierre Milcendeau
Pierre Milcendeau
NSNazarii Sabat
Nazarii Sabat
AFAngélique Ferry
Angélique Ferry
XGXavier Guinchard
Xavier Guinchard
This review documents the potential of enantioselective gold catalysis for the functionalization of indoles.

12 May 2020 in Organic Letters
Verified
Journal Article
Closed access
NSNazarii Sabat
Nazarii Sabat
FSFeryel Soualmia
Feryel Soualmia
PRPascal Retailleau
Pascal Retailleau
ABAlhosna Benjdia
Alhosna Benjdia
OBOlivier Berteau
Olivier Berteau
XGXavier Guinchard
Xavier Guinchard

29 September 2016 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
NSNazarii Sabat
Nazarii Sabat
LSLenka Poštová Slavětínská
Lenka Poštová Slavětínská
BKBlanka Klepetářová
Blanka Klepetářová
MHMichal Hocek
Michal Hocek

13 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
NSNazarii Sabat
Nazarii Sabat
ASAndreas Stämpfli
Andreas Stämpfli
SHSteven Hanlon
Steven Hanlon
SBSerena Bisagni
Serena Bisagni
FSFilippo Sladojevich
Filippo Sladojevich
MHMarcel Hollenstein
Marcel Hollenstein
Chemical modification of DNA is a common strategy to improve the properties of oligonucleotides, particularly for therapeutics and nanotechnology. Existing synthetic methods essentially rely on phosphoramidite chemistry or the polymerization of nucleoside triphosphates but are limited in terms of size, scalability, and sustainability. Herein, we report a robust alternative method for the de novo synthesis of modified oligonucleotides using template-dependent DNA ligation of shortmer fragments. Our approach is based on the fast and scaled accessibility of chemically modified shortmer monophosphates as substrates for the T3 DNA ligase. This method has shown high tolerance to chemical modifications, flexibility, and overall efficiency, thereby granting access to a broad range of modified oligonucleotides of different lengths (20 → 120 nucleotides). We have applied this method to the synthesis of clinically relevant antisense drugs and ultramers containing diverse modifications. Furthermore, the designed chemoenzymatic approach has great potential for diverse applications in therapeutics and biotechnology.

1 February 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NSNazarii Sabat
Nazarii Sabat
EMEvelyne Migianu-Griffoni
Evelyne Migianu-Griffoni
TTTiffany Tudela
Tiffany Tudela
MLMarc Lecouvey
Marc Lecouvey
SKSabrina Kellouche
Sabrina Kellouche
Nadege LUBIN-GERMAINNadege LUBIN-GERMAIN
Nadege LUBIN-GERMAIN

20 April 2022 in Chemistry – A European Journal
Verified
Journal Article
Closed access
FSFeryel SOUALMIA
Feryel SOUALMIA
AGAlain Guillot
Alain Guillot
NSNazarii Sabat
Nazarii Sabat
CBClémence Brewee
Clémence Brewee
XKXavier Kubiak
Xavier Kubiak
OBOlivier Berteau
Olivier Berteau